HOME >> BIOLOGY >> NEWS
Multiple-drug resistant gene expression pattern predicts treatment outcome for pediatric leukemia

A new study is providing scientists with a better understanding of why some pediatric acute lymphoblastic leukemia (ALL) patients fail to respond to treatment even when existing clinical predictive criteria point towards a positive treatment outcome. The research, published in the April issue of Cancer Cell, is likely to facilitate development of new strategies to combat drug resistance and treatment failure for children with ALL.

Nearly 80% of children with ALL are cured following chemotherapeutic treatment. However, the remaining 20% often exhibit drug resistance and treatment failure that is poorly understood. In some cases, patients are resistant to multiple drugs that have very little structural similarity, suggesting that the mechanisms for drug cross-resistance are probably not the same as mechanisms underlying resistance to a single drug. Dr. William E. Evans from St. Jude Children's Research Hospital and colleagues used a comprehensive genetic screening technique to search for genes that are differentially expressed in ALL cells that demonstrated cross-resistance to two or more commonly used chemotherapeutic agents.

The researchers identified several genes that were differentially expressed in ALL cells that exhibited de novo cross resistance to four widely used antileukemic agents. They went on to investigate the relationship of these genes to treatment outcome in ALL patients and found that expression of the genes was associated with treatment outcome and could be used to identify a subset of patients with a markedly inferior response to treatment. In addition, the findings revealed a previously unrecognized phenotype characterized by discordant resistance to two widely used and mechanistically distinct antileukemic agents and provided new information about the cellular mechanisms involved in disparate response to these drugs.

Specific genetic signatures related to ALL treatment failure and chemotherapeutic cross-resistance w
'"/>

Contact: Heidi Hardman
hhardman@cell.com
1-617-397-2879
Cell Press
18-Apr-2005


Page: 1 2

Related biology news :

1. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate
2. New way to target and kill antibiotic-resistant bacteria found
3. First all-African produced genetically engineered maize is resistant to maize streak virus
4. Malaria-resistant mosquitoes battle disease with molecular warhead
5. Wellcome Trust and GlaxoSmithKline announce partnership to target drug-resistant hospital infections
6. Arming the fight against resistant bacteria
7. Researchers uncover protection mechanism of radiation-resistant bacterium
8. Will the plague pathogen become resistant to antibiotics?
9. Trojan horse strategy defeats drug-resistant bacteria
10. Breakthrough vaccine to treat chemo-resistant ovarian cancer
11. Protein discovery targets antibiotic-resistant bacteria

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/18/2019)... ... March 18, 2019 , ... uBiome, the leader in ... third highest quality portfolio following Seres Health and Nestle, as published in ... Theodor Myfleler. uBiome executives Dr. Jessica Richman, PhD, co-founder and CEO, Dr. Zachary ...
(Date:3/14/2019)... Va. (PRWEB) , ... March 13, 2019 , ... Bode Technology (Bode), a ... DNA testing on more than 100,000 sexual assault kits. As thousands of untested kits ... eliminate sexual assault kit backlogs . Bode has tested more than 50,000 kits ...
(Date:3/12/2019)... , ... March 12, 2019 , ... ... multi-factor authentication and combined technology all-in-one smart cards, announced today the launch of ... authentication: the Fingerprint Biometric and Dynamic CVV Payment cards. These advanced technologies will ...
Breaking Biology News(10 mins):
(Date:3/14/2019)... ... March 14, 2019 , ... ... standard solution for preclinical research organizations. It is a low code, GDPR/21 ... systems and facilities, innovative technology-driven automated data capture and seamless data and ...
(Date:3/11/2019)... ... March 11, 2019 , ... In this live webinar, the featured ... clinical trial efficiency and experience. Participants will learn how to use the information they ... ensure that the simple or complex randomization scheme is properly designed and set up ...
(Date:3/9/2019)... ... March 08, 2019 , ... OnlineMasters.com, ... the release of their Best Online Master's in Biotechnology Programs for 2019. ... quality, program flexibility, affordability, and graduate outcomes. , In addition to insights ...
(Date:3/4/2019)... (PRWEB) , ... March 04, 2019 , ... Stay on top of current hot topics ... Access to all webinars is free, so be sure to register today to save your ... to see our upcoming webinars: , CLINICAL TRIALS, , March ...
Breaking Biology Technology:
Cached News: